108 related articles for article (PubMed ID: 8380737)
21. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
Zhang YW; Vande Woude GF
J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
[TBL] [Abstract][Full Text] [Related]
22. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
23. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
24. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
25. The role of Ito cells in the biosynthesis of HGF-SF in the liver.
Schirmacher P; Geerts A; Jung W; Pietrangelo A; Rogler CE; Dienes HP
EXS; 1993; 65():285-99. PubMed ID: 8380738
[TBL] [Abstract][Full Text] [Related]
26. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways.
Warn R; Harvey P; Warn A; Foley-Comer A; Heldin P; Versnel M; Arakaki N; Daikuhara Y; Laurent GJ; Herrick SE; Mutsaers SE
Exp Cell Res; 2001 Jul; 267(2):258-66. PubMed ID: 11426944
[TBL] [Abstract][Full Text] [Related]
27. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met.
Weidner KM; Hartmann G; Sachs M; Birchmeier W
Am J Respir Cell Mol Biol; 1993 Mar; 8(3):229-37. PubMed ID: 8383506
[TBL] [Abstract][Full Text] [Related]
28. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
29. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
30. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.
Uehara Y; Minowa O; Mori C; Shiota K; Kuno J; Noda T; Kitamura N
Nature; 1995 Feb; 373(6516):702-5. PubMed ID: 7854453
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor stimulates growth of hematopoietic progenitor cells.
Mizuno K; Higuchi O; Ihle JN; Nakamura T
Biochem Biophys Res Commun; 1993 Jul; 194(1):178-86. PubMed ID: 8392836
[TBL] [Abstract][Full Text] [Related]
32. [Influence of scatter factor/hepatocyte growth factor on the growth and transmission of hepatocarcinoma SMMC 7721 cells].
Xie Q; Liu K; Hu M; Wu X; Zhou K
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):95-7. PubMed ID: 11350688
[TBL] [Abstract][Full Text] [Related]
33. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
Soldati C; Biagioni S; Poiana G; Augusti-Tocco G
J Neurosci Res; 2008 Apr; 86(5):1044-52. PubMed ID: 17975841
[TBL] [Abstract][Full Text] [Related]
34. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis.
Wang Y; Selden C; Farnaud S; Calnan D; Hodgson HJ
J Anat; 1994 Dec; 185 ( Pt 3)(Pt 3):543-51. PubMed ID: 7649790
[TBL] [Abstract][Full Text] [Related]
36. [Hepatocarcinogenesis in terms of HGF and its receptor].
Kanda H; Kitagawa T
Nihon Rinsho; 1993 Feb; 51(2):380-5. PubMed ID: 8385239
[TBL] [Abstract][Full Text] [Related]
37. Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation.
Raiber EA; Wilkinson JA; Manetti F; Botta M; Deakin J; Gallagher J; Lyon M; Ducki SW
Bioorg Med Chem Lett; 2007 Nov; 17(22):6321-5. PubMed ID: 17870532
[TBL] [Abstract][Full Text] [Related]
38. Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung.
Kagoshima M; Kinoshita T; Matsumoto K; Nakamura T
Eur J Biochem; 1992 Nov; 210(1):375-80. PubMed ID: 1332867
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer.
Nagy J; Curry GW; Hillan KJ; McKay IC; Mallon E; Purushotham AD; George WD
Surg Oncol; 1996 Feb; 5(1):15-21. PubMed ID: 8837300
[TBL] [Abstract][Full Text] [Related]
40. Scatter factor and its relationship to hepatocyte growth factor and met.
Rosen EM; Knesel J; Goldberg ID
Cell Growth Differ; 1991 Nov; 2(11):603-7. PubMed ID: 1839956
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
